BM
Brandywine Managers’s Relay Therapeutics RLAY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $133K | Hold |
38,429
| – | – | 0.13% | 35 |
|
2025
Q1 | $101K | Hold |
38,429
| – | – | 0.12% | 34 |
|
2024
Q4 | $158K | Hold |
38,429
| – | – | 0.17% | 35 |
|
2024
Q3 | $272K | Buy |
38,429
+6,622
| +21% | +$46.9K | 0.29% | 31 |
|
2024
Q2 | $207K | Hold |
31,807
| – | – | 0.22% | 32 |
|
2024
Q1 | $264K | Hold |
31,807
| – | – | 0.26% | 34 |
|
2023
Q4 | $350K | Hold |
31,807
| – | – | 0.38% | 32 |
|
2023
Q3 | $267K | Hold |
31,807
| – | – | 0.45% | 32 |
|
2023
Q2 | $399K | Hold |
31,807
| – | – | 0.26% | 38 |
|
2023
Q1 | $524K | Hold |
31,807
| – | – | 0.37% | 31 |
|
2022
Q4 | $475K | Hold |
31,807
| – | – | 1.66% | 22 |
|
2022
Q3 | $712K | Hold |
31,807
| – | – | 2.34% | 11 |
|
2022
Q2 | $533K | Buy |
31,807
+6,382
| +25% | +$107K | 1.31% | 24 |
|
2022
Q1 | $761K | Hold |
25,425
| – | – | 1.31% | 21 |
|
2021
Q4 | $781K | Buy |
25,425
+3,702
| +17% | +$114K | 0.89% | 27 |
|
2021
Q3 | $685K | Hold |
21,723
| – | – | 0.72% | 29 |
|
2021
Q2 | $795K | Buy |
21,723
+1,771
| +9% | +$64.8K | 0.91% | 24 |
|
2021
Q1 | $690K | Buy |
19,952
+11,702
| +142% | +$405K | 0.92% | 25 |
|
2020
Q4 | $343K | Hold |
8,250
| – | – | 0.47% | 37 |
|
2020
Q3 | $351K | Buy |
+8,250
| New | +$351K | 0.67% | 30 |
|